Table 3.
Multivariable Cox models for PSM dataset (n = 872)
| PFS | OS | LRRFS | DMFS | |||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) |
p value | HR (95% CI) |
p value | HR (95% CI) |
p value | HR (95% CI) |
p value | |
| Age | NS | 0.004 | NS | NS | ||||
| ≤ 45 | Reference | |||||||
| > 45 | 3.16(1.44–6.92) | |||||||
| N stage | < 0.001 | 0.002 | < 0.001 | NS | ||||
| N0 | Reference | Reference | Reference | |||||
| N1 | 2.44(1.48–4.00) | 4.14(1.67–10.16) | 3.50(1.73–7.07) | |||||
| EBV DNA | 0.042 | NS | < 0.001 | |||||
| < 4000 | Reference | Reference | ||||||
| ≥ 4000 | 1.74(1.01–2.97) | 3.55(1.84–6.85) | ||||||
| PET/CT obtained | 0.262 | 0.196 | 0.526 | 0.182 | ||||
| Yes | Reference | Reference | Reference | Reference | ||||
| No | 0.72(0.40–1.28) | 0.56(0.23–1.35) | 0.79(0.38–1.64) | 0.49(0.17–1.40) | ||||
p value < 0.05 indicates a statistically significant difference
Abbreviations: PFS, progression-free survival; OS, overall survival; LRRFS, locoregional relapse-free survival; DMFS, distant metastasis-free survival